According to the latest market report published by Credence Research, Inc. “Psoriasis Treatment Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025” the global Psoriasis Treatment market was valued at US$ 7.9 Bn in 2016, and is expected to reach US$ 12.8 Bn by 2025, expanding at a CAGR of 5.4% from 2017 to 2025.
Browse the full report Psoriasis Treatment Market – Growth, Future Prospects and Competitive Analysis, 2017 – 2025 at http://www.credenceresearch.com/report/psoriasis-treatment-market
Psoriasis is a chronic, inflammatory, painful skin disease for which there is no cure with great negative impact on patient’s quality of life. Primary goal of treatment is to reduce inflammation and to stop the skin cells from growing quickly. Psoriasis treatment market is rapidly growing due to factors such as growing prevalence in some countries, significant unmet needs, promising pipeline molecules would drive the growth of psoriasis market worldwide. For the purpose of study, global psoriasis treatment market is segmented on the basis of drug class such as TNF Inhibitors, Vitamin D analogues, interleukin blockers and other psoriasis medication. It is observed that, in the base year 2016, interleukin blockers was major revenue contributing segment due to its long-term safety with lower risk of infection and malignancy. Psoriasis treatment market is categorized on the basis of route of administration such as topical, oral and parenteral therapeutic drugs. Currently, topical therapeutic drugs hold largest market share due to its safety, more effectiveness and targeted drug delivery. It is anticipated that parenteral therapeutic drugs would show significant growth during forecast period because newly approved biologics are generally preferred in moderate to severe psoriasis. Psoriasis treatment market is currently dominated by North America, factors such as higher cost of therapy, higher number of psoriasis patient, government reimbursement policies fueling the growth of psoriasis treatment market in North America.
Market Competition Assessment:
The psoriasis treatment market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as AbbVie Inc., Amgen Inc., AstraZeneca, Biogen, Boehringer Ingelheim, Celgene, Eli Lilly and Company, Johnson & Johnson, LEO Pharma A/S, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Stiefel Laboratories Inc. (GlaxoSmithKline plc.), Sun Pharmaceutical Industries and other.
Download Free Sample Request: http://www.credenceresearch.com/sample-request/58469
Key Market Movements:
- Factors such as higher prevalence psoriasis disease, increasing treatment awareness, higher treatment compliance and favorable reimbursement policies in some countries are driving the market growth of psoriasis treatment worldwide.
- Due to the high unmet needs, vendors in the market are focusing in development of ideal treatment, promising pipeline molecule, rising access for the treatment medication in some developing countries, increase in incidence of psoriasis and skin disorders would fuel the growth of psoriasis treatment market during forecast period.
- However, patent expiry of blockbuster drugs leads to generic erosion and adverse effects associated with the use of medication which would negatively impact the growth of psoriasis treatment market.
Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE,
CA 95103, United States